Role of Cardiac MRI in Evaluation of Ischemic Heart Disease

Cardiac Magnetic Resonance (CMR) has established itself as the non-invasive gold standard for myocardial tissue characterization. In ischemic heart disease (IHD), its utility extends far beyond simple ejection fraction quantification, providing the granular tissue-level data required to formulate complex, lifetime management strategies.

Here is a breakdown of its primary clinical roles in evaluating IHD.

1. Viability Assessment and Scar Quantification

Late Gadolinium Enhancement (LGE) is the cornerstone of viability testing. Because gadolinium cannot cross intact cell membranes, it washes out of healthy myocardium but accumulates in the expanded extracellular space of fibrotic or infarcted tissue.

Ischemic LGE strictly follows a coronary territory. Because ischemic necrosis originates in the subendocardium and progresses outward (the wavefront phenomenon), ischemic scar will always involve the subendocardium. If the subendocardium is spared, the etiology is non-ischemic.

The transmural extent of LGE inversely correlates with the probability of functional recovery following revascularization (the Kim criteria):

Transmural Extent of LGE	Likelihood of Functional Recovery
0% (No LGE)	Very High (~80%)
1-25%	High (~60%)
26-50%	Moderate (~40%)
51-75%	Low (~10%)
76-100%	Very Low (<1%)

Translating these imaging findings into surgical outcomes requires clinical nuance. For instance, data from the 10-year follow-up of the STICH viability cohort demonstrates that while the presence of viable myocardium is associated with better overall long-term survival, it does not necessarily identify patients who will derive a differential mortality benefit from CABG over medical therapy. This highlights why viability testing is just one piece of a broader clinical puzzle.

2. Differentiating MINOCA and STEMI Mimics

When evaluating Acute Coronary Syndromes (ACS), particularly Myocardial Infarction with Non-Obstructive Coronary Arteries (MINOCA), CMR is the definitive diagnostic tool to rule out clinical mimics.

By combining T2-weighted imaging (which highlights edema) with LGE, you can definitively distinguish between ischemic and non-ischemic acute presentations:

• Acute Myocardial Infarction: Shows focal T2 edema matching a specific coronary territory, with corresponding subendocardial or transmural LGE.
• Myocarditis: Typically presents with patchy, nodular, or band-like T2 edema and LGE in the epicardial or mid-wall layers, distinctly sparing the subendocardium.
• Takotsubo Cardiomyopathy: Demonstrates global or regional T2 edema matching the wall motion abnormality (often apical ballooning), but strictly lacks any LGE, confirming the absence of irreversible necrosis.

3. Assessing Acute Infarct Complications

In the immediate post-MI setting, CMR provides unique prognostic markers that independently predict adverse LV remodeling and mortality, often overriding standard LVEF measurements:

• Microvascular Obstruction (MVO): Represents the “no-reflow” phenomenon. It appears as a dark, hypo-enhanced core within the bright LGE region because the contrast cannot penetrate the severely damaged microvasculature. MVO persistence between EGE and LGE images was a significant independent predictor of MACE.
• Intramyocardial Hemorrhage (IMH): Detected as a hypointense core on T2* (T2-star) sequences, representing extravasation of red blood cells into the necrotic tissue. IMH is a highly specific marker for severe reperfusion injury.
• Myocardial Salvage Index (MSI): EGE was collected at 3 minutes after contrast agent injection, where hyperintense areas were considered as the area at risk. MSI was calculated as the ratio of salvageable myocardium to the area at risk. A larger MSI indicates a highly successful reperfusion strategy. Every 10% increase in MSI was associated with a 32% reduction in major adverse cardiac event risk.

4. Stress Perfusion CMR

For detecting inducible ischemia, first-pass vasodilator perfusion (using adenosine or regadenoson) is highly effective. It tracks the first pass of gadolinium through the myocardium; ischemic beds supplied by stenotic arteries show delayed wash-in, appearing as a dark subendocardial rim.

Because of its superior spatial resolution compared to SPECT and lack of ionizing radiation, it is particularly valuable for detecting subendocardial ischemia and identifying multi-vessel disease that might otherwise present as “balanced ischemia” on nuclear imaging.